TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Arcadia Biosciences ( (RKDA) ).
Arcadia Biosciences, Inc. has announced that its 2025 annual meeting of stockholders will be held on December 19, 2025. The company has also informed stockholders of a change in the meeting date and updated deadlines for submitting proposals and nominations for the meeting. This announcement follows a Securities Exchange Agreement with Roosevelt Resources, LP, which involves an all-stock transaction for the combination of the two companies. The meeting and the proxy statement are separate from the special meeting related to this transaction.
The most recent analyst rating on (RKDA) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on Arcadia Biosciences stock, see the RKDA Stock Forecast page.
Spark’s Take on RKDA Stock
According to Spark, TipRanks’ AI Analyst, RKDA is a Neutral.
Arcadia Biosciences faces significant financial and valuation challenges, with unprofitability and negative cash flow being major concerns. Technical analysis provides some mixed signals, but overall, the stock lacks strong positive indicators. The absence of earnings call data and corporate events further limits the assessment.
To see Spark’s full report on RKDA stock, click here.
More about Arcadia Biosciences
Average Trading Volume: 519,204
Technical Sentiment Signal: Sell
Current Market Cap: $5.32M
For a thorough assessment of RKDA stock, go to TipRanks’ Stock Analysis page.